News Boehringer to develop fibrosis treatment with Inventiva Boehringer to progress R&D partnership that began last year
News Galapagos and FibroGen drugs offer hope in IPF Drugs improve on existing medicines from Boehringer and Roche.
Views & Analysis Patient perspective: living with rare lung disease IPF Idiopathic pulmonary fibrosis (IPF) is a fatal disease that's all the more difficult for patients because of a lack of awareness and investment in supporting people with the condition.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.